Forte Biosciences

$39.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.70 (+4.48%) Today

$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell FBRX and other stocks, options, and ETFs commission-free!

About FBRX

Forte Biosciences, Inc. Common Stock, also called Forte Biosciences, is a clinical stage dermatology company focuses in the treatment of inflammatory skin diseases. It offers FB-401, a live bio-therapeutic product. The company was founded by Paul A. Wagner in 2017 and is headquartered in Torrance, CA. The listed name for FBRX is Forte Biosciences, Inc. Common Stock.

CEO

Paul A. Wagner

Employees

Headquarters

Torrance, California

Founded

—

Market Cap

519.59M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

61.17K

High Today

$39.99

Low Today

$38.01

Open Price

$38.50

Volume

45.07K

52 Week High

$53.99

52 Week Low

$6.45

Collections

FBRX Earnings

-$9.52

-$6.35

-$3.17

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 25, After Hours